247 related articles for article (PubMed ID: 18378264)
1. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
Smolders I; Clinckers R; Meurs A; De Bundel D; Portelli J; Ebinger G; Michotte Y
Neuropharmacology; 2008 May; 54(6):1017-28. PubMed ID: 18378264
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
Neuropharmacology; 2004 Dec; 47(7):1053-61. PubMed ID: 15555639
[TBL] [Abstract][Full Text] [Related]
3. Differential glutamatergic modulation of monoamine release in the limbic lobe by selective anticonvulsant ionotropic and metabotropic glutamate receptor ligands.
Smolders I
Verh K Acad Geneeskd Belg; 2005; 67(5-6):371-98. PubMed ID: 16408832
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
J Neurochem; 2004 May; 89(4):834-43. PubMed ID: 15140183
[TBL] [Abstract][Full Text] [Related]
5. In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin.
Clinckers R; Gheuens S; Smolders I; Meurs A; Ebinger G; Michotte Y
Epilepsia; 2005 Jun; 46(6):828-36. PubMed ID: 15946324
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal dopamine and serotonin elevations as pharmacodynamic markers for the anticonvulsant efficacy of oxcarbazepine and 10,11-dihydro-10-hydroxycarbamazepine.
Clinckers R; Smolders I; Meurs A; Ebinger G; Michotte Y
Neurosci Lett; 2005 Dec; 390(1):48-53. PubMed ID: 16139430
[TBL] [Abstract][Full Text] [Related]
7. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
8. The 5-HT(7) receptor as a mediator and modulator of antidepressant-like behavior.
Sarkisyan G; Roberts AJ; Hedlund PB
Behav Brain Res; 2010 May; 209(1):99-108. PubMed ID: 20097233
[TBL] [Abstract][Full Text] [Related]
9. Effects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activity.
Golembiowska K; Kowalska M; Bymaster FP
Synapse; 2012 May; 66(5):435-44. PubMed ID: 22213370
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Weikop P; Kehr J; Scheel-Krüger J
J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
[TBL] [Abstract][Full Text] [Related]
12. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands.
Smolders I; Lindekens H; Clinckers R; Meurs A; O'Neill MJ; Lodge D; Ebinger G; Michotte Y
J Neurochem; 2004 Mar; 88(5):1068-77. PubMed ID: 15009663
[TBL] [Abstract][Full Text] [Related]
13. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
[TBL] [Abstract][Full Text] [Related]
14. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
[TBL] [Abstract][Full Text] [Related]
15. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors.
Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ
Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993
[TBL] [Abstract][Full Text] [Related]
16. The effects of LPM570065, a novel triple reuptake inhibitor, on extracellular serotonin, dopamine and norepinephrine levels in rats.
Zhang R; Li X; Shi Y; Shao Y; Sun K; Wang A; Sun F; Liu W; Wang D; Jin J; Li Y
PLoS One; 2014; 9(3):e91775. PubMed ID: 24614602
[TBL] [Abstract][Full Text] [Related]
17. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ
Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
Murray F; Hutson PH
Eur J Pharmacol; 2007 Aug; 569(1-2):41-7. PubMed ID: 17582397
[TBL] [Abstract][Full Text] [Related]
19. Seizure activity and changes in hippocampal extracellular glutamate, GABA, dopamine and serotonin.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Epilepsy Res; 2008 Jan; 78(1):50-9. PubMed ID: 18054462
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.
Belozertseva IV; Kos T; Popik P; Danysz W; Bespalov AY
Eur Neuropsychopharmacol; 2007 Feb; 17(3):172-9. PubMed ID: 16630709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
